Allstate Corp Eli Lilly & CO Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

A detailed history of Allstate Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Allstate Corp holds 729 shares of LLY stock, worth $570,930. This represents 0.06% of its overall portfolio holdings.

Number of Shares

729

Previous 2,689 72.89%

Holding current value

$570,930

Previous $2.43 Million 73.5%

% of portfolio

0.06%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $1.51 Million - $1.88 Million	-1,960 Reduced 72.89%	729 $645,000
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $34,793 - $43,633	-48 Reduced 1.75%	2,689 $2.43 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $8,883 - $11,884	-15 Reduced 0.55%	2,737 $2.13 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $80,354 - $94,726	-153 Reduced 5.27%	2,752 $1.6 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $10.6 Million - $12.5 Million	-34,149 Reduced 92.16%	2,905 $997,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $100,002 - $116,522	311 Added 0.85%	37,054 $13.6 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $36,513 - $42,872	-131 Reduced 0.36%	36,743 $11.9 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $4.37 Million - $5.43 Million	-18,630 Reduced 33.57%	36,874 $10.6 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $8.3 Million - $10.3 Million	36,910 Added 198.5%	55,504 $15.3 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $400,874 - $493,332	-1,809 Reduced 8.87%	18,594 $4.3 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $315,962 - $408,695	-1,750 Reduced 7.9%	20,403 $4.68 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $250,259 - $323,972	1,523 Added 7.38%	22,153 $4.14 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $26,874 - $35,561	206 Added 1.01%	20,630 $3.48 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $632,986 - $732,163	-4,329 Reduced 17.49%	20,424 $3.02 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $389,615 - $468,898	-2,856 Reduced 10.34%	24,753 $4.06 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $7.62 Million - $9.44 Million	-64,032 Reduced 69.87%	27,609 $3.83 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $213 - $264	-2 Reduced -0.0%	91,641 $12 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.24 Million - $1.35 Million	-11,639 Reduced 11.27%	91,643 $10.2 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1,661 - $1,939	-15 Reduced 0.01%	103,282 $11.4 Million
Q1 2019 May 20, 2019	SELL	$111.31 - $131.02 $1,558 - $1,834	-14 Reduced 0.01%	103,297 $13.4 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $10.9 Million - $12.3 Million	103,311 New	103,311 $12 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account